Tuesday, October 13, 2026

USD/EUR Rises By 2% In The Last 21 Sessions

ViaNews Editorial Team

February 14, 2024

USD/EUR Rises By 2% In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 2.19% for the last 21 sessions. At 07:10 EST on Wednesday, 14 February, USD/EUR (USDEUR) is $0.93.

USD/EUR's yearly highs and lows, it's 5.266% up from its 52-week low and 2.445% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.12%, a positive 0.09%, and a positive 0.32%, respectively.

USD/EUR's highest amplitude of average volatility was 0.12% (last week), 0.25% (last month), and 0.32% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be overbought (>=80).

News about

  • According to FXStreet on Tuesday, 13 February, "Eren Sengezer, European Session Lead Analyst at FXStreet, offers a brief technical outlook for EUR/USD and explains: "EUR/USD holds steady at around 1.0800, where the 100-day Simple Moving Average (SMA) and the Fibonacci 50% retracement of the October-December uptrend align. "
  • Eur/usd: low for longer outlook – rabobank. According to FXStreet on Monday, 12 February, "This factor, combined with the potentially USD supportive factors identified above, underpins our view that EUR/USD is likely to be more comfortable in a 1.0400 to 1.1200 range over the next 24 months or so than at levels over 1.1500."
  • Eur/usd analysis: warning of oversold levels - 12 February 2024. According to DailyForex on Monday, 12 February, "According to the performance on the daily chart above, the general trend of the EUR/USD pair is still bearish, and as we mentioned before, moving below the psychological support level of 1.0800 will support the bears to move further downward. "
  • Eur/usd churns on Monday with pair hampered by technical barriers. According to FXStreet on Monday, 12 February, "The pair remains capped by the 200-hour Simple Moving Average (SMA), and Monday's test above 1.0800 saw the EUR/USD quickly rejected back into the 1.0770 region.", "The EUR/USD remains down over 3% from December's peak bids near 1.1150, and a bearish trend sees little topside potential for the pair as the 50-day SMA turns bearish and is set for a downside crossover of the 200-day SMA."
  • Eur/usd can find some support back above 1.0800 – ING. According to FXStreet on Monday, 12 February, "The holding pattern that EUR/USD has shown recently may well remain the norm in the coming weeks.", "We see some modest downside risks for the Dollar this week, and think EUR/USD can find some support back above 1.0800, although a return to the 1.0930/1.0950 area looks premature."

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic AI Rewires Enterprise Software: Platform Incumbents, Governance, and a Funded Startup Wave
Enterprise software is being rebuilt around autonomous AI agents. Incumbents and large platforms (SAP with its Autonomous Suite and Joule, Zeta with AthenaOS/AIM/Athena MCP, Meta with its new Enterprise Platform) are racing to own the agent layer. Meanwhile, seed and Series A money flows to finance-office and vertical startups (Dextr, Latitude, Dentira, Light), and consolidation continues through acquisitions (Tiny–Oso Cloud, Harvey–Guardrails AI). Investor commentary stresses that AI is better at disrupting around the edges of systems of record than at replacing them, that it should not be trusted with finance calculations, and that governance must be enforced by the system rather than left to agents.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,371 source documents archived
Query this data → isubstrate.com